Frontlight ResearchEarly access
Trial site
CHUM-Hosp de Univ Montreal
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Obesity2 trials
- Heart failure1 trial
- Sickle cell disease1 trial
- Phase
- Phase 33 trials
- Status
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S3 trials
Running trials
Not yet recruiting
Recruiting
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Heart failure1 recruiting
- Sickle cell disease1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026